Home > Insider Trading > Filing (0001666071-20-000018)

Filing Details

Accession Number:: 0001666071-20-000018
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-28 17:40:03
Reporting Period:: 2020-01-27

Accepted Time:: 2020-01-28 17:40:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1666071	Cardlytics Inc.	CDLX	Services-Computer Programming, Data Processing, Etc. (7370)	263039436

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1730451	Thomas David Evans	C/O Cardlytics, Inc. 675 Ponce De Leon Avenue Ne, Suite 6000 Atlanta GA 30308	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-01-27	53,757	$20.00	75,993	No	4	M	Direct
Common Stock	Acquisiton	2020-01-27	28,906	$20.00	104,899	No	4	M	Direct
Common Stock	Acquisiton	2020-01-27	25,781	$30.44	130,680	No	4	M	Direct
Common Stock	Disposition	2020-01-27	29,096	$83.99	101,584	No	4	S	Direct
Common Stock	Disposition	2020-01-27	30,425	$85.06	71,159	No	4	S	Direct
Common Stock	Disposition	2020-01-27	24,635	$85.80	46,524	No	4	S	Direct
Common Stock	Disposition	2020-01-27	9,937	$86.97	36,587	No	4	S	Direct
Common Stock	Disposition	2020-01-27	5,777	$87.68	30,810	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2020-01-27	53,757	$0.00	53,757	$20.00
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2020-01-27	28,906	$0.00	28,906	$20.00
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2020-01-27	25,781	$0.00	25,781	$30.44

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,250	2026-08-02	No	4	M	Direct
8,594	2026-12-06	No	4	M	Direct
11,719	2027-07-07	No	4	M	Direct

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $83.43 to $84.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $84.44 to $85.43, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $85.44 to $86.40, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $86.44 to $87.43, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $87.44 to $88.11, inclusive.
This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on June 15, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The options becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.